Speaker:

Jennifer Smith

Learning Objectives:

• Describe the pharmacokinetics and pharmacodynamics of linezolid and the role of therapeutic drug monitoring
• Identify patient populations that would benefit from linezolid therapeutic drug monitoring
• Analyze real world data to establish evidence-based practices for fixed-based dosing versus individualized dosing for linezolid
• Develop a dosing and therapeutic drug monitoring plan for a patient treated with linezolid

Disclosure:
Jennifer has no relevant financial relationships to disclose.